Clinical Trial Detail

NCT ID NCT00776867
Title Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

Advanced Solid Tumor

Therapies

Perifosine

Age Groups: child

No variant requirements are available.